Amgen Valuation
| AMG Stock | EUR 264.15 1.00 0.38% |
At this time, the firm appears to be overvalued. Amgen Inc shows a prevailing Real Value of €228.65 per share. The current price of the firm is €264.15. Our model approximates the value of Amgen Inc from analyzing the firm fundamentals such as current valuation of 163.09 B, and Price To Sales of 5.64 X as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Amgen's price fluctuation is very steady at this time. Calculation of the real value of Amgen Inc is based on 3 months time horizon. Increasing Amgen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Amgen's intrinsic value may or may not be the same as its current market price of 264.15, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 264.15 | Real 228.65 | Hype 264.15 | Naive 269.19 |
The intrinsic value of Amgen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Amgen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Amgen Inc helps investors to forecast how Amgen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Amgen more accurately as focusing exclusively on Amgen's fundamentals will not take into account other important factors: Amgen Total Value Analysis
Amgen Inc is presently forecasted to have takeover price of 163.09 B with market capitalization of 105.18 B, debt of 37.35 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Amgen fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
163.09 B | 105.18 B | 37.35 B |
Amgen Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of Amgen implies not a very effective usage of assets in December.Amgen Profitability Analysis
The company reported the revenue of 26.32 B. Net Income was 6.55 B with profit before overhead, payroll, taxes, and interest of 0.About Amgen Valuation
The stock valuation mechanism determines Amgen's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Amgen Inc based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Amgen. We calculate exposure to Amgen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Amgen's related companies.8 Steps to conduct Amgen's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Amgen's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Amgen's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Amgen's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Amgen's revenue streams: Identify Amgen's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Amgen's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Amgen's growth potential: Evaluate Amgen's management, business model, and growth potential.
- Determine Amgen's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Amgen's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Amgen Stock Analysis
When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.